메뉴 바로가기
주메뉴 바로가기
컨텐츠 바로가기

COMPANY

Mission&Vision

LuxBiome

A leading microbiome R&D company creating global innovative drugs

Global Microbiome Drug Development

R&D Capabilities

30 Years of
Microbiome Research

 

  • R&D Funding
    KRW 38.5B

  • Int'l Journals
    197 Papers

  • Patents
    55 Cases

Drug Discovery Platform

Multi-modality system

Target-specific biomarker discovery, efficacy prediction, and high clinical success rates

  • Microbial
    Resources

  • Genomic
    DB

  • Machine
    Learning

Global Competitiveness

Pandemic Vaccines/Drugs
& Medifood Development

 

  • Medifood

  • Innovative
    Drugs

  • ODA

Luxbiome Global Business Roadmap

  • 01

    Discovery of candidate functional materials
    using the Pangenome Miner platform

  • 02

    Validation through
    preclinical studies

  • 03

    Development of premium medifood
    through human clinical trials

  • 04

    Commercialization of First-in-class innovative drugs
    (Joint development & commercialization of
    LBP with Global Big Pharma)